Please use this identifier to cite or link to this item:
Title: Thai perilla (Perilla frutescens) leaf extract inhibits human breast cancer invasion and migration
Authors: Komsak Pintha
Payungsak Tantipaiboonwong
Supachai Yodkeeree
Wittaya Chaiwangyen
Orada Chumphukam
Orawan Khantamat
Chakkrit Khanaree
Napapan Kangwan
Benchaluk Thongchuai
Maitree Suttajit
Keywords: Multidisciplinary
Issue Date: 1-May-2018
Abstract: © 2018 by Maejo University, San Sai, Chiang Mai, 50290 Thailand. Thai perilla (Perilla frutescens), also called Nga-mon, contains a substantial quantity of bioactive substances including phenolics and flavonoids. These phytochemicals have been linked to various bioactivities of P. frutescens such as in vitro and in vivo anti-inflammatory, anti-oxidative and anti-cancer capacities. In this study we evaluated anti-invasive and anti-migratory activities of Thai perilla leaf extract (PLE) on human breast cancer cells, MDA-MB-231. Our results demonstrate that rosmarinic acid is the main constituent of PLE. In vitro cytotoxicity analysis shows that PLE, at 24-hr exposure, is not toxic to MDA-MB-231 cells. A Boyden chamber-based transmembrane assay shows that PLE at a non-toxic dose (12.5-50 µg/mL) dramatically exhibits an inhibitory effect on cell invasion and migration. Gelatin zymography shows that PLE at a concentration of 100-400 µg/mL dose-dependently decreases matrix metalloproteinase-9 (MMP-9) secretion (p < 0.05-0.001) and activity (p < 0.001). Our data indicate that PLE can inhibit breast cancer cell invasion and migration through the reduction in activity and availability of MMP-9. Our observations also suggest that rosmarinic acid in PLE may account for the anti-invasion and anti-migration activities. In particular, rosmarinic acid as a food-derived chemotherapeutic agent can potentially be used in cancer chemotherapy.
ISSN: 19057873
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.